SEC filingsOct 12, 2026 to Oct 19, 2026: insiders reported 840 purchases and sales across 212 companies.840 insider purchases and sales in 7 daysSee the filings →
HornScout

Company profile

TXMD

TherapeuticsMD, Inc.
NASDAQHealth Care

Latest close: 1.90 USD · Oct 16, 2026 · 1 year · split-adjusted

On the price, the facts of the public record■Insider buy□Insider sell●Results filed
With an account, also○dividends▲splits◌next earningswith an account

End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.

Latest on record

The most recent facts, as filed.

Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.

  1. Aug 11, 2026Quarterly report · 10-QFiled by the company itself.Open the filing ↗
  2. Aug 11, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  3. May 12, 2026Quarterly report · 10-QFiled by the company itself.Open the filing ↗

In numbers

What this profile holds, counted.

Closes · 1 year250
SEC filings on record1,0727 flagged findings
Reported transactions (Form 4)70since Jan 23, 2023
Corporate events (8-K)30since Jun 3, 2022

What the record says

Description, identity and filings, each with its source.

Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.

SEC topics

Regulatory history

Topics detected in its SEC reports, with the original excerpt.

Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.

  • 2026-03-30share offering or dilution eventrecentOpen filing ↗
    “…to the rules of the SEC and generally means that a person has beneficial ownership of a security if he, she, or it possesses…”
    +1 more passage from the same document
    • “…sole or shared voting or investment power of that security, including options and warrants that are currently exercisable or…”
  • 2026-03-30listing compliance noticerecentOpen filing ↗
    “…effectively. ● Our success is tied to the distribution channels of our licensees. ● Any failure of our licensees to adequately…”
    +1 more passage from the same document
    • “…nominal other assets is generally considered to be a public shell company. Listed companies determined to be public shell companies…”
  • 2026-03-30Department of Justice inquiryrecentOpen filing ↗
    “…before a trial is completed; ● labeling, marketing, or promotional changes and/or restrictions; ● product recalls or withdrawals;…”
    +1 more passage from the same document
    • “…are subject to extensive and costly government regulation. Our products are subject to extensive and rigorous domestic government…”
  • 2026-03-30merger or acquisition eventrecentOpen filing ↗
    “…Health Network, Inc., and the Major Shareholders(1) 2.2 Agreement and Plan of Reorganization, dated June 11, 2010, among AMHN,…”

Original excerpts from SEC filings, untranslated. Not advice and not a prediction.

Reverse splits in 5 years

1 reverse split in 5 years (1:50 on May 9, 2022) · 1:50 cumulative

The other times: of 818 securities that did their first reverse split in 5 years, a year later the median was worth 0.53× the price on the day of the split; 382 lost more than half and 209 rose (809 with a price a year later).

Our own series, not the whole market: based on the splits we have on record (provider and SEC); an unrecorded one does not count. Historical distribution, not a prediction.

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

The 25 most recent filings (of 1,072)

Everything filed

Every SEC filing, newest first, with what it is. Below, each type with its own explanation.

  • Aug 11, 2610-Q ↗Quarterly report
  • Aug 11, 268-K ↗Current report · Results · Communication to the market
  • Aug 5, 26SCHEDULE 13G/A ↗Passive stake · Baselake Partners, LP · 6.8% · event on Jun 30, 26 · amendment
  • May 12, 2610-Q ↗Quarterly report
  • May 12, 268-K ↗Current report · Results · Communication to the market
  • Apr 6, 26SCHEDULE 13G ↗Passive stake · Baselake Partners, LP · 5.2% · event on Mar 30, 26
  • Apr 1, 2610-K/A ↗Annual report · amendment
  • Apr 1, 26NT 10-K ↗Late filing notice
  • Mar 30, 268-K ↗Current report · Results · Communication to the market
  • Mar 30, 2610-K ↗Annual report
  • Jan 21, 268-K ↗Current report · Auditor change filing (8-K Item 4.01)
  • Dec 29, 25Form 4 ↗Insider transaction
  • Dec 16, 258-K ↗Current report · Shareholder vote results
  • Nov 13, 258-K ↗Current report · Results · Communication to the market
  • Nov 12, 2510-Q ↗Quarterly report
  • Insider transaction · 4 Form 4 filingsshow all 4hide
  • Nov 3, 25DEFA14A ↗Shareholder meeting and votes
  • Nov 3, 25DEF 14A ↗Shareholder meeting and votes
  • Oct 24, 25PRE 14A ↗Shareholder meeting and votes
  • Aug 12, 2510-Q ↗Quarterly report
  • Aug 12, 258-K ↗Current report · Results · Communication to the market
  • May 13, 2510-Q ↗Quarterly report

1,072 filings on record, the oldest from Aug 16, 95.

Listing the 25 most recent filings of the 1,072 on record.

8-Ks, explained

Stress10Structure97Governance60
  • Jan 21, 26GovernanceAuditor change filing (8-K Item 4.01)+1 more in the same filing8-K 4.01 ↗
  • Aug 18, 23StructureEntered a material agreement+1 more in the same filing8-K 1.01 ↗
  • Jul 10, 23GovernanceAuditor change filing (8-K Item 4.01)+1 more in the same filing8-K 4.01 ↗
  • Jul 6, 23StructureSold unregistered shares+2 more in the same filing8-K 3.02 ↗
  • May 5, 23StructureEntered a material agreement8-K 1.01 ↗
  • Feb 27, 23GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
  • Jan 18, 23GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Jan 12, 23StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Jan 6, 23GovernanceA senior executive left or was appointed+1 more in the same filing8-K/A 5.02 ↗
  • Jan 3, 23StructureCompleted an acquisition or disposal+6 more in the same filing8-K 2.01 ↗
  • Dec 5, 22StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Dec 1, 22StructureEntered a material agreement8-K 1.01 ↗

10 older filings not shown · The record reaches back to Apr 11, 05.

Notable in the record

Stress disclosures older than the timeline above. They are individual events from the record, not a complete timeline: there may be more between them.

  • Apr 20, 22StressA debt obligation was accelerated+2 more in the same filing8-K 2.04 ↗
  • Mar 18, 22StressListing notice (8-K 3.01)+1 more in the same filing8-K 3.01 ↗
  • Sep 17, 21StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Apr 25, 19StressA debt obligation was accelerated+5 more in the same filing8-K 2.04 ↗
  • Apr 17, 19StressA debt obligation was accelerated+5 more in the same filing8-K 2.04 ↗
  • Sep 25, 17StressListing notice (8-K 3.01)+2 more in the same filing8-K 3.01 ↗
  • Jul 2, 10StressA debt obligation was accelerated+1 more in the same filing8-K 2.04 ↗
  • Jun 24, 10StressA debt obligation was accelerated+1 more in the same filing8-K 2.04 ↗
  • Nov 17, 05StressPast accounts declared unreliable and being restated8-K 4.02 ↗

The full record holds 10 stress filings.

Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.

Ownership and control

Schedule 13G: short-form filing

The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.

  • Baselake Partners, LP6.8%Jun 30, 26SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
  • Clearline Capital LP5.5%Dec 31, 24SCHEDULE 13G ↗3 co-filers on this document — the figure is the largest single stake, not their sum.

Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.

SEC record

Insider transactions

Buys and sells reported by officers, directors and major shareholders on SEC Form 4.

Buys and sells

  • Dec 23, 25Buy$14KTommy G Thompson↗
  • Apr 14, 25Buy$489Marlan D WalkerChief Executive Officer↗
  • Apr 14, 25Buy$326Tommy G Thompson↗
  • Apr 10, 25Buy$1KMarlan D WalkerChief Executive Officer↗
  • Apr 9, 25Buy$994Marlan D WalkerChief Executive Officer↗
  • Aug 22, 24Buy$7KCooper C. Collins↗
  • Aug 21, 24Buy$2KCooper C. Collins↗
  • Dec 7, 23Sell$10KMarlan D WalkerChief Executive Officer↗
  • Dec 6, 23Sell$33KMarlan D WalkerChief Executive Officer↗
  • Apr 26, 23Sell$3KMarlan D WalkerChief Executive Officer↗
  • Apr 12, 23Sell$4KMarlan D WalkerChief Executive Officer↗
  • Jan 27, 23Sell$249Michael C DoneganPrin. Fin. and Acctg. Officer↗

There are 3 more transactions in this stretch.

Stock compensation, tax and giftsshow the 25 other transactionshide

Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.

  • Feb 18, 25Compensationamount n/aMarlan D WalkerChief Executive Officer↗
  • Feb 18, 25Compensationamount n/aMarlan D WalkerChief Executive Officer↗
  • Feb 18, 25Compensationamount n/aMarlan D WalkerChief Executive Officer↗
  • Feb 18, 25Compensationamount n/aMarlan D WalkerChief Executive Officer↗
  • Feb 18, 25Compensationamount n/aTommy G Thompson↗
  • Feb 18, 25Compensationamount n/aGail K Naughton↗
  • Feb 18, 25Compensationamount n/aCooper C. Collins↗
  • Dec 5, 23Compensationamount n/aMarlan D WalkerChief Executive Officer↗
  • Nov 15, 23Compensation$2.0MRubric Capital Management LP↗
  • Aug 17, 23Compensationamount n/aJOSEPH ZIEGLERPrincipal Financial Officer↗
  • Jun 28, 23Compensation$1.1MRubric Capital Management LP↗
  • Apr 26, 23Compensationamount n/aMarlan D WalkerChief Executive Officer↗
  • Apr 26, 23Compensationamount n/aMarlan D WalkerChief Executive Officer↗
  • Apr 12, 23Compensationamount n/aMichael C DoneganPrin. Fin. and Acctg. Officer↗
  • Apr 12, 23Compensationamount n/aMarlan D WalkerChief Executive Officer↗
  • Apr 12, 23Compensationamount n/aMarlan D WalkerChief Executive Officer↗
  • Apr 12, 23Compensationamount n/aMarlan D WalkerChief Executive Officer↗
  • Apr 12, 23Compensationamount n/aMarlan D WalkerChief Executive Officer↗
  • Jan 26, 23Compensationamount n/aMichael C DoneganPrin. Fin. and Acctg. Officer↗
  • Jan 26, 23Compensationamount n/aMichael C DoneganPrin. Fin. and Acctg. Officer↗
  • Jan 26, 23Compensationamount n/aMichael C DoneganPrin. Fin. and Acctg. Officer↗
  • Jan 23, 23Compensationamount n/aMichael C DoneganPrin. Fin. and Acctg. Officer↗
  • Jan 23, 23Compensationamount n/aMichael C DoneganPrin. Fin. and Acctg. Officer↗
  • Jan 23, 23Compensationamount n/aMichael C DoneganPrin. Fin. and Acctg. Officer↗
  • Jan 23, 23Compensationamount n/aMichael C DoneganPrin. Fin. and Acctg. Officer↗

The full record holds 43 transactions and goes back to Dec 8, 22.

Its sector and its market

TherapeuticsMD, Inc. among Health Care companies

The profile shows what is on record. Context and Radar place the company among those of its sector and region.

With an account you also get

  • The four engines — growth, trend, risk and context — each with its word and its score.
  • The risk band and the sector phase.
  • The company's fundamentals and accounts.
  • Watchlist: your list of companies, with the «since you follow it» figure.

The research continues

The profile tells the story. The market sets the scene.

From TherapeuticsMD, Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.

  1. Place it in its market

    Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.

    See how Context works →
  2. See what deserves a closer look

    Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.

    See how Radar works →
  3. Keep the why

    Follow TherapeuticsMD, Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.

    See an example review →

Coverage

What sits behind this page.

Where each figure comes from and how far it reaches.

Prices
End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
Series quality
250 clean closes in the period.
SEC records
1,072 documents on file, from Aug 16, 1995 to Aug 11, 2026.
Company description
No description available.
This page
Generated on Oct 19, 2026; refreshed through the day.

Start at your own pace

Explore first. Go deeper with access.

Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.

Compare plans →
  • No account

    This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.

  • Pro

    What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.

  • Pro+

    Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.

Are the prices real time?

No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.

Which SEC documents appear here?

Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.

Why does a European company show no SEC records?

It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.

Before forming a view on a company,
read what is on record.

One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.

Access by invitation while the beta lasts. Not advice: the profile shows what is on record; it does not recommend.